3309 — C-Mer Medical Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapFalling Star

Annual cashflow statement for C-Mer Medical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	C2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	53.2	2.5	26.9	-11.2	124
Depreciation
Amortisation
Non-Cash Items	-0.807	11.9	-9.93	10.1	-2.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	5.85	-18.4	-21.1	-57.7	18.4
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	137	110	144	165	361
Capital Expenditures	-172	-33.4	-122	-91.2	-116
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-87.5	-120	-274	-104	-130
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-259	-153	-396	-196	-245
Financing Cash Flow Items	-0.848	-10.4	0.49	-7.63	-20.8
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-66.6	312	85.1	294	-243
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-190	272	-167	258	-132